UK markets open in 2 hours 43 minutes
NIKKEI 225
39,076.45 +459.35 (+1.19%) HANG SENG
18,930.02 -265.58 (-1.38%) CRUDE OIL
77.09 -0.48 (-0.62%) GOLD FUTURES
2,374.20 -18.70 (-0.78%) DOW
39,671.04 -201.95 (-0.51%) Bitcoin GBP
54,542.87 -310.60 (-0.57%)
Veru Inc. (VERU)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 1.3900 |
| Open | 1.3700 |
| Bid | 1.3600 x 700 |
| Ask | 1.3900 x 1400 |
| Day's range | 1.3400 - 1.4100 |
| 52-week range | 0.3600 - 1.9200 |
| Volume | |
| Avg. volume | 2,418,982 |
| Market cap | 203.474M |
| Beta (5Y monthly) | -0.20 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 28 Apr 2014 |
| 1y target est | N/A |
- Simply Wall St.
Individual investors account for 48% of Veru Inc.'s (NASDAQ:VERU) ownership, while institutions account for 25%
Key Insights Veru's significant individual investors ownership suggests that the key decisions are influenced by...
- GuruFocus.com
Veru Inc (VERU) Q2 2024 Earnings Call Transcript Highlights: Strategic Focus and Financial Recovery
Explore key insights from Veru Inc's Q2 2024 earnings, emphasizing improved financial management and strategic advancements in pharmaceutical development.
- GuruFocus.com
Veru Inc. (VERU) Fiscal 2024 Q2 Earnings: Clinical Advances Amid Financial Strains
Veru's Innovative Clinical Programs Progress as Financial Challenges Persist
© 2024 Yahoo. All rights reserved.